Posts

Showing posts from February, 2011

Terbutaline: Label Change - Warnings Against Use for Treatment of Preterm Labor

Image
Death and serious adverse reactions, including increased heart rate, transient hyperglycemia, hypokalemia, cardiac arrhythmias, pulmonary edema, and myocardial ischemia have been reported after prolonged administration of oral or injectable terbutaline to pregnant women.

Warming Injections May Take Out the Sting

Image
An injection of local anesthetic can be made much less painful if it is warmed beforehand, Canadian researchers report.

Vaccines, Autism, and Dipshit Jenny McCarthy

By the time you read this, the Vaccine = Autism published by the BJM will be old news (Yes, I do write a bunch of rants at once and have them post at a later date). However lets take a closer look at this whole situation. The Angry Pharmacist » Blog Archive » Vaccines, Autism, and Dipshit Jenny McCarthy :

Symptoms in the Pharmacy :Gastrointestinal Tract Problems(13)

Constipation in practice Case 1 Mr Johnson is a middle-aged man who occasionally visits your pharmacy. Today he complains of constipation, which he has had for several weeks. He has been having a bowel movement every few days; normally they are every day or every other day.

Giving Baby Solid Foods Too Early Linked to Obesity Later

Image
 Babies who were formula-fed and introduced to solid foods before they were 4 months old were more likely to be obese when they were 3, researchers report.

Symptoms That May Indicate Preeclampsia

Image
Preeclampsia occurs when a pregnant woman's blood pressure spikes rapidly. It can lead to stroke, organ failure and other life-threatening conditions in both the mother and baby. The American Congress of Obstetricians and Gynecologists says possible warning signs of preeclampsia include: Headaches. Vision abnormalities. Quickly gaining weight. Swollen face and hands.

"Makena" FDA Approves First Drug to Prevent Premature Births

FRIDAY, Feb. 4 -- The U.S. Food and Drug Administration has approved the first drug to help prevent premature birth in women who have had at least one previous preterm delivery. The drug -- called Makena (hydroxyprogesterone caproate) -- is expected to reduce the risk of premature delivery, which experts say raises the risk of infant complications at birth, lifelong disabilities such as cerebral palsy, and even death. Preterm delivery is a serious problem in the United States, FDA spokeswoman Shelly Burgess said.